Key Study Findings and Future Plans
Vaxart, Inc recently published complete data from its Phase 1b trial of its first-generation oral norovirus vaccine, demonstrating encouraging results in elderly adults. The study showed that the vaccine was capable of inducing strong antibody and T-cell responses in adults aged 55-80, a group known to experience weakened immune responses to traditional injectable vaccines. The […]
Cautionary Tale Associated in Trial With Rare Error in Cox Regression
The German company InflaRx has developed an investigational therapy, vilobelimab, which is being studied for SARS-CoV-2-induced acute respiratory distress syndrome (ARDS). Vilobelimab is a first-in-class monoclonal antihuman complement factor C5a antibody. In one of its trials, the FDA recommended that the company use a site stratification adjustment. “We had the FDA recommending us to do […]
Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine
Image credits: Vaxart Inc Vaxart, Inc announced the publication of complete data from its Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly adults. The trial demonstrated the vaccine’s ability to induce strong antibody and T-cell responses in adults aged 55-80, a population known to experience age-related declines in immune responses […]
Texas Outbreak Increases, Northeast Reports Cases, CDC Deployed to Help
On Tuesday, the Texas Department of State Health Services provided an update on the measles outbreak in there. Authorities reported there were 159 cases have been identified with 22 of the patients being hospitalized in western counties in the state. Gaines county has reported the highest number of cases with 107. There has been 1 […]
HIV Viral Suppression With Long-Acting Antiretroviral Therapy
This study uses electronic medical record data to compare 48-week viral load outcomes after starting long-acting antiretroviral therapy among people in the US with HIV with or without viremia from January 2021 through September 2024. Source link
